Vivos Therapeutics, Inc. Proceeds from Sale and Collection of Notes Receivable
Vivos Therapeutics, Inc. (VVOS) reported Proceeds from Sale and Collection of Notes Receivable of $975.00 thousand for the 0-month period ending 2019-10-02, per its 10-Q filed 2021-11-15.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndCollectionOfNotesReceivable · last filed 2021-11-15
- 2019-10-02: Proceeds from Sale and Collection of Notes Receivable 0 month $975.00K.
| Period end | Proceeds from Sale and Collection of Notes Receivable 0 month |
|---|---|
| 2019-10-02 | $975.00K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |